Stay Vigilant Against COVID-19 With Veredus Diagnostics Solutions

As the world adapts to COVID-19, how has the pandemic shaped your perspectives on challenges faced and strategies on implementing your laboratory’s solutions for clinical testing? Through a variety of current strategies for molecular tests for the detection of SARS-CoV-2 and rapid antibody detection using serological testing, we are proud to make a positive impact to the development and progress of people’s lives and society.

VereRTCoV™ SARS-CoV-2 Real-Time RT-PCR 2.0 is a one-step Reverse Transcription Polymerase Chain Reaction (RT-PCR)-based In Vitro Diagnostic (IVD) test intended for the qualitative detection of nucleic acid belonging to SARS-CoV-2 on a qPCR cycler. The real-time RT-PCR test has obtained approvals from the Health Sciences Authority (HSA) Singapore and the Food and Drug Administration (FDA) of the Philippines for In vitro diagnostic (IVD) use.

The real-time RT-PCR test delivers a test sensitivity of Limit of Detection (LOD) as low as two viral RNA copies per reaction, with no cross-reactivity with human genome / other coronaviruses / respiratory viruses. Setting up your Real-time PCR is simple with premixed reagents, so you can free up time to make decisions that matter in your work.

Together with the VerePLEX™ Lab-on-Chip Platform, VereCoV™ Detection Kit is capable of detecting, differentiating and identifying SARS-CoV-2 and SARS-CoV in a single test. The VereCoV™ Detection Kit delivers test results in less than 2.5 hours using the VerePLEX™ Biosystem platform which integrates both PCR and microarray technologies. Both VerePLEX™ Biosystem and VereCoV™ Detection Kit have obtained approvals for In IVD use by HSA Singapore, and also available as a CE-IVD test.

LIONRUN Diagnostic Kit for Antibody IgM/IgG of Novel Coronavirus COVID-19 is an IVD test for the qualitative and differential detection of IgM and IgG antibodies against SARS-CoV-2 in human whole blood, serum or plasma within 10 minutes. The rapid antibody test has obtained Provisional Authorisation for IVD use in HSA Singapore and also CE marking for diagnostic use across Europe. Now more than ever, we need to stay in the know about what we can do to support the fight against COVID-19 and to mitigate the fear and anxiety. I wish you good health and stay safe during the coronavirus pandemic. And thank you for reading our article.